Joseph M Lane (J Lane)
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 18
Publications (10 Years): 18
Publications
- Joseph M Lane, Bente Lomholt Langdahl, M Stone, A Kurth, Mary Oates, J Timoshanko, Zhenxun Wang, Cesar Libanati, Felicia CosmanRomosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (7) (2024)
- Joseph M Lane, Bente Lomholt Langdahl, M Stone, A Kurth, Mary Oates, J Timoshanko, Zhenxun Wang, Cesar Libanati, Felicia CosmanRomosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (7) (2024)
- Lisa A Mandl, Mangala Rajan, Robyn A Lipschultz, Serena Lian, Dina Sheira, Marianna B Frey, Yvonne M Shea, Joseph M Lane
- Joseph M Lane, Bente Lomholt Langdahl, M Stone, A Kurth, Mary Oates, J Timoshanko, Zhenxun Wang, Cesar Libanati, Felicia CosmanRomosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (7) (2024)
- Joseph M Lane, Bente Lomholt Langdahl, M Stone, A Kurth, Mary Oates, J Timoshanko, Zhenxun Wang, Cesar Libanati, Felicia CosmanRomosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (7) (2024)
- Lisa A Mandl, Mangala Rajan, Robyn A Lipschultz, Serena Lian, Dina Sheira, Marianna B Frey, Yvonne M Shea, Joseph M Lane
- Joseph M Lane, Bente Lomholt Langdahl, M Stone, A Kurth, Mary Oates, J Timoshanko, Zhenxun Wang, Cesar Libanati, Felicia CosmanRomosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
- Teerapat Tutaworn, Jeri W Nieves, Zhaorui Wang, Justin E Levin, Jae E Yoo, Joseph M LaneBone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
- Teerapat Tutaworn, Jeri W Nieves, Zhaorui Wang, Justin E Levin, Jae E Yoo, Joseph M LaneBone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 34 (3) (2023)
- Teerapat Tutaworn, Jeri W Nieves, Zhaorui Wang, Justin E Levin, Jae E Yoo, Joseph M LaneBone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 34 (3) (2023)
- Teerapat Tutaworn, Jeri W Nieves, Zhaorui Wang, Justin E Levin, Jae E Yoo, Joseph M LaneBone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
- Teerapat Tutaworn, Jeri W Nieves, Zhaorui Wang, Justin E Levin, Jae E Yoo, Joseph M LaneBone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 34 (3) (2023)
- Teerapat Tutaworn, Jeri W Nieves, Zhaorui Wang, Justin E Levin, Jae E Yoo, Joseph M LaneBone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 34 (3) (2023)
- Guang-Ting Cong, Arielle J Hall, Zhimeng Jia, Anthony V Christiano, Hannah C K Elsevier, Zoe B Cheung, David S Wellman, David Forsh, Joseph M Lane
- Derek G Hansen, Teerapat Tutaworn, Joseph M Lane